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Abstract
Background: A novel, bead-based flow cytometric assay was developed for simultaneous determination of
antibody responses against Toxoplasma gondii and Trichinella spiralis in pig serum. This high throughput screening
assay could be an alternative for well known indirect tests like ELISA. One of the advantages of a bead-based assay
over ELISA is the possibility to determine multiple specific antibody responses per single sample run facilitated by a
series of antigens coupled to identifiable bead-levels. Furthermore, inclusion of a non-coupled bead-level in the
same run facilitates the determination of, and correction for non-specific binding. The performance of this bead-
based assay was compared to one T. spiralis and three T. gondii ELISAs. For this purpose, sera from T. gondii and T.
spiralis experimentally infected pigs were used. With the experimental infection status as gold standard, the area
under the curve, Youden Index, sensitivity and specificity were determined through receiver operator curve
analysis. Marginal homogeneity and inter-rater agreement between bead-based assay and ELISAs were evaluated
using McNemar’s Test and Cohen’s kappa, respectively.
Results: Results indicated that the areas under the curve of the bead-based assay were 0.911 and 0.885 for T. gondii
and T. spiralis, respectively, while that of the T. gondii ELISAs ranged between 0.837 and 0.930 and the T. spiralis ELISA
was 0.879. Bead-based T. gondii assay had a sensitivity of 86% and specificity of 96%, while the ELISAs ranged between
64-84% and 93-99%, respectively. The bead-based T. spiralis assay had a sensitivity of 68% and specificity of 100% while
the ELISA scored 72% and 95%, respectively. Marginal homogeneity was found between the T. gondii bead-based test
and one of the T. gondii ELISAs. Moreover, in this test combination and between T. spiralis bead-based assay and
respective ELISA, an excellent inter-rater agreement was found. When results of samples before expected
seroconversion were removed from evaluation, notably higher test specifications were found.
Conclusions: This new bead-based test, which detects T. gondii and T. spiralis antibodies simultaneously within
each sample, can replace two indirect tests for the determination of respective antibodies separately, while
performing equally well or better.
Background
Trichinella spiralis and Toxoplasma gondii are well
known zoonoses which can pass from pigs to humans
by consumption of raw or undercooked infected pork.
In humans, most cases of T. gondii and T. spiralis
infections go undetected; however, some cases can lead
to mild disease. Other cases of trichinellosis can be very
severe and may lead to myocarditis, encephalitis or
pneumonia. Post natal acquired toxoplasmosis can inci-
dentally lead to encephalitis and necrotizing retinochor-
oiditis, while congenital transmitted toxoplasmosis can
lead to mental retardation, convulsions, spasticity, cere-
bral palsy, deafness and severely impaired vision in the
offspring. In rare occasions, both these infections can
lead to death.
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These days, in Europe, trichinellosis is rarely reported
in association with the consumption of pork from con-
ventionally raised pigs [1]. An EU regulation [2] directs
inspection of T. spiralis in each pig carcass at slaughter
by direct parasitological methods. This regulation also
states that serological tests may be implemented as a
supplement for monitoring purposes.
Unlike T. spiralis, no such regulations exist for T. gon-
dii, although the prevalence of this parasite in pigs is
higher and health consequences of toxoplasmosis can
be, like those of trichinellosis, rather serious. For exam-
ple, in a Dutch survey in 2004, T. gondii infection was
found in 2.6% of the studied pigs [3], while in that year
none of the over 13 million slaughtered pigs were found
T. spiralis positive [4].
Consumption of raw or undercooked T. gondii
infected pork may cause toxoplasmosis in humans.
Obviously, determination of the T. gondii status of the
meat producing pigs, subsequently followed by precau-
tionary methods, like freezing of pork to kill the parasite
or altogether removal of this meat from the food chain,
could contribute to fewer infections in humans. A
Dutch study which assessed the epidemiology and
impact of, amongst others, T. gondii infections in
humans indicated that this parasite is one of the major
contributors of disease through zoonotic transmission
[5]. Similarly, an American study indicated that T. gondii
in pork ranked second on the list of the zoonotic micro-
organisms with the greatest impact on annual disease
burden in that country [6] and was only surpassed by
Campylobacter in chicken. In a scientifically opinion to
the European Food Safety Authority (EFSA) it is recom-
mended that standardized methods should be used on
T. gondii pre-harvest monitoring of, amongst others,
pigs [7].
Like T. spiralis, the T. gondii infection status of ani-
mals can be examined by serological tests in order to
produce T. gondii controlled pork. Testing serum sam-
ples of finisher pigs requires an automated and easy to
perform test method with a high sensitivity (Se) and
specificity (Sp). Enzyme-linked immunosorbent assays
(ELISAs) are such test methods which are commonly
used.
Bead-based assays (BBA) are a new dimension in the
determination of specific antibody responses. The test is
performed on beads which are available in different
sizes and levels. During flow cytometric analysis indivi-
dual beads are distinguishable by size and intrinsic
fluorescence intensity level. The bead surface is carboxy-
late modified, which allows covalent coupling of protein.
The great advantage of these tests over ELISA is the
possibility of simultaneous detection of specific
responses against multiple antigens per single serum
sample. More specifically, by individual coupling of
antigens to specific bead levels, and combination of
these bead levels per test sample, a multitude of specific
responses can be determined simultaneously per sample.
Furthermore, by the use of a non-coupled bead, non-
specific binding (NSB) can be monitored and corrected
for. The use of T. gondii and T. spiralis antigens on two
bead levels in a combined bead-based test to determine
the serological status of swine would provide a new
innovative assay which could be used as an alternative
to ELISA in a T. gondii and T. spiralis monitoring
system.
In this report, the specifications of a bead-based array
test, with combined T. gondii and T. spiralis antigen
bead levels to determine specific antibodies in serum of
experimentally infected swine, are evaluated and com-
pared to commercial and non-commercial ELISAs.
Methods
Porcine sera
Experimental infection sera
Swine serum samples originated from an experimental
co-infection of pigs with T. gondii and T. spiralis [8].
Before infection, animals used in the experiment were
assumed T. gondii and T. spiralis free on basis of the
post partum determined negative serological status of
sows which gave birth to these animals [8]. Briefly, eight
to nine week old animals had been singly (T. gondii n =
8, T. spiralis n = 10), simultaneously (n = 10), or succes-
sively (T. gondii/T. spiralis n = 9, T. spiralis/T. gondii n
= 10) orally inoculated with either 2,700 or 2,000 T.
gondii tissue cysts (strain DX) and/or 5,000 T. spiralis
muscle larvae (strain ISS 14) per pig. Because two ani-
mals of the T. spiralis/T. gondii inoculated group did
not seem to be infected, they were excluded from the
experiment [8]. A total of 444 serum samples were col-
lected in series at 0, 5, 12, 19, 26, 33, 40, 47 and 54 days
post infection (p.i.) from 45 pigs and four additional
non-inoculated animals which served as negative control
animals. This animal study, under number DEC 2008.
III.03.023, was reviewed and approved by the local ani-
mal ethics committee according to the recommenda-
tions of the EU directive 86/609/EEC. Numbers of
animals and their suffering were minimized.
Negative field sera
Blood samples of conventional finisher pigs were col-
lected for Salmonella baseline monitoring at the abattoir
in 2007 by the Dutch Food and Consumer Product
Safety Authority (nVWA). The blood was left at room
temperature with a minimum of 2 hours to clot and
subsequently centrifuged for 10 minutes at 1,100 × g.
Serum was drawn and dispensed in aliquots and kept at
-20°C until further use.
Serum samples were analyzed by a commercially
obtained T. gondii ELISA (ID Screen Toxoplasmosis
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Indirect, ID-VET, Montpellier, France; hereafter referred
as E3-TOX). Serum samples remaining under the desig-
nated cut-off value of the ELISA were considered to ori-
ginate from T. gondii infection negative pigs. Because
during the sample period no pigs with T. spiralis infec-
tions were reported [9], all animals were considered T.
spiralis infection negative.
Indirect assays
Sera from the experimentally infected animals were
tested by the bead-based assay for T. gondii and T. spir-
alis antibodies simultaneously (hereafter referred to as
BBA-TOX and BBA-TRI, respectively), by an RIVM in-
house T. gondii ELISA (hereafter referred to as E1-
TOX) and two commercially available T. gondii ELISA
kits (Safepath, Carlsbath, CA, USA, hereafter referred to
as E2-TOX) and E3-TOX, and by one T. spiralis ELISA
(Safepath, hereafter referred to as E-TRI). All T. gondii
indirect tests used an antigen based on T. gondii tachy-
zoites, of which E3-TOX utilized a recombinant tachy-
zoite surface protein (SAG-1) as antigen. The T. spiralis
tests were based on ES antigens. Bead-based assays were
run according to the specifications described in the sec-
tion bead-based assay. Testing with the in-house ELISA
[3] was described earlier [8] and included an intra-plate
correction of E1-TOX data. All commercial ELISAs
were run according to the specification of the kit provi-
ders. For E3-TOX, normalization of data was included.
Bead-based assay
A bead-based assay was developed for simultaneous
detection of specific antibodies which were captured by
T. spiralis and T. gondii antigens on two different bead
levels. NSB was recorded with reference beads, which is
a bead level without coupled antigens. Each bead level
was recognized via the emission of light with a unique
intensity and wavelength of the beads intrinsic fluores-
cence. Specific and NSB in each individual serum sam-
ple were determined by the extrinsic response, which
was generated by the emission of light by a fluorophore
attached to the secondary antibody. Because NSB may
vary between serum samples, the extrinsic response of
reference beads was used to determine the non-specific
response. To obtain a specific response per individual
serum sample, this non-specific response was subtracted
from the response of coupled beads. A BD Accuri flow
cytometer was used for enumeration of micro-particles,
excitation of fluorescent markers and measurement of
emitted light from these markers.
Chemicals, materials and solutions
L4, L10 and L11 carboxylated Cyto-plex™ beads (cat#
FM5CR04, FM5CR10 and FM5CR11, respectively) were
purchased from Thermo Scientific (Waltham, MA,
USA). T. gondii tachyzoite lysate, strain RH (cat#:
R29123) was from Meridian Life Science Inc. (Saco, ME,
USA). T. spiralis Excretory/Secretory antigen (ES) was
obtained from Instituto Superiore Sanità (Rome, Italy).
Microcentrifuge copolymer tubes (cat# 1415-2500) were
acquired from Star Lab GmbH (Ahrensberg, Germany).
N-hydroxysulfosuccinimide sodium salt (sNHS), N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochlor-
ide (EDC; cat#: 03449) and 2-(N-morpholino)ethanesul-
fonic acid hydrate (MES; cat#: M8250) were bought
from Sigma-Aldrich Chemie B.V. (Zwijndrecht, the
Netherlands). A 45 mM MES buffer was prepared and
adjusted to pH 6.0 with sodium hydroxide. PBS at pH
7.2 consisted of 0.01 M sodium chloride (NaCl, Merck
KGaA, Darmstadt, Germany), 1 mM di-sodium hydro-
gen phosphate (Merck) and 3 mM potassium dihydro-
gen phosphate (Merck). Water was of milliQ quality.
Storage buffer and HNT-PBS solution were provided by
RnAssays (Utrecht, the Netherlands). The 0.45 μm filter
plates (cat#: MSHVN4550) were from Millipore
(Amsterdam, the Netherlands). Goat anti-swine second-
ary antibody conjugated with fluorescent DyLight 488
was purchased from Jackson Immuno Research (West
Grove, PA, USA).
Bead coupling procedure
T. gondii tachyzoite lysate and T. spiralis Excretory/
Secretory antigen (ES) were coupled to carboxylated
beads through an amine coupling procedure. Briefly, an
equivalent of 1.4 × 108 carboxylated beads of L10 and
L11 were transferred to two 1.5 ml copolymer tubes.
The beads were washed by three repeats of following
steps: a 3 minutes centrifugation at 9,000 ×g, removal of
the supernatant, addition of 1 ml water per tube and
resuspension of the beads on a vortex. After the third
removal of supernatant, beads from both tubes were
resuspended in 1.1 ml solution consisting of 12.5 mg
sNHS and 12.5 mg EDC in MES buffer. This suspension
was incubated for 20 minutes at room temperature on a
gyro rocker at 70 rpm. Beads were washed 2 more times
with 500 μl water as described above and after removal
of the supernatant, 50 μg of T. gondii lysate and 10 μg
T. spiralis ES dissolved in 200 μl PBS pH 7.4 were
added to the activated L10 and L11 beads, respectively.
Resuspended beads were left to incubate for 2 hours on
a gyro rocker at 70 rpm, washed and stored in a storage
buffer. A non-coupled L4 reference bead suspension was
produced with the same protocol with exception of the
protein incubation step which was substituted by PBS
incubation. This L4 bead is referred to as the reference
bead.
Assay procedure
Two 0.45 μm filter plates were soaked with 150 μl of a
0.2 μm filtered solution of HNT-PBS, subsequently
incubated for five minutes at ambient temperature, and
emptied by vacuum filtration. Serum samples were
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diluted 1:50 in HNT-PBS, transferred to a soaked and
aspirated 0.45 μm filter plate, filtered with the use of the
vacuum manifold and collected in an empty 96-wells
plate. Thereafter, in another soaked filter plate, a quan-
tity of approximately 5 × 105 T. gondii and T. spiralis
antigen coupled beads and reference beads were sus-
pended in 50 μl of HNT-PBS per well. Subsequently,
one equivalent volume of filtered diluted sera was mixed
and incubated with the bead-mix per well for 15 min-
utes on an orbital shaker (1,050 rpm). Beads were
washed with 200 μl HNT-PBS by aspiration and addi-
tionally incubated with 100 μl 1:300 in HNT-PBS
diluted fluorescent secondary antibody for 15 minutes.
Finally, beads were washed once more and suspended in
100 μl HNT-PBS. Due to light sensitivity of beads and
fluorescent reporter the filter plates were protected from
light during incubation steps.
Internal and external fluorescent detection
A total of 600 beads per serum sample were analyzed
for the intrinsic bead label on the FL4 channel, and
extrinsic fluorescence reporter label on the FL1 channel
using a BD Accuri C6 flow cytometer (BD Accuri Cyt-
ometers, Inc. Ann Arbor, MI, USA). The detector was
equipped with a CSampler liquid handler (BD Accuri)
and operated through CFlow software (version 1.0.243.1,
BD Accuri). Beads were transported at a flow rate of 35
μl/min. The emission of the intrinsic fluorescence of the
three bead levels, measured by the FL4 filter at 675 nm,
was used to distinguish the T. gondii (TOX), T. spiralis
(TRI) and reference (REF) beads. The median extrinsic
fluorescence intensity (MFI) of the secondary antibody
per bead level was determined by measuring the emis-
sion via the FL1 filter at 530 nm.
Correction for non-specific binding
Reference beads were used to indicate the measure of
NSB in the test. Differences in NSB on uncoupled or
antigen coupled bead levels may be expected due to dif-
ferences in affinity of beads for non-specific antibodies
caused by the molecular structure of the antigen, its
orientation and concentration on the bead surface.
Therefore, to estimate the NSB on T. gondii and T. spir-
alis bead levels from the response of a reference bead, a
correction factor was calculated by testing 932 T. gondii
and 13 extra T. spiralis negative swine sera (section
Negative field sera) in the bead-based assay. With the
use of least square regression, linear relations, expressed
with the formulae y = slope*x + intercept, the relation
between responses of the reference beads (x value) and
T. gondii and T. spiralis bead responses (y values) were
calculated in SPSS 16.0 for Windows (SPSS Inc., Chi-
cago, IL, USA). Because the residuals of the linear rela-
tion between responses of T. gondii and T. spiralis bead
levels and reference bead responses were not normally
distributed, all responses were log transformed.
Normalization of responses
To compare results between 96-wells plates, serum sam-
ples responses were normalized. The percentage of nor-
malized responses (%NR) was calculated as a percentage
of sample responses (MFIS) of a positive control
response (MFIPC), which was present in quadruplicate
on each plate, after subtraction of NSB (sections Correc-
tion for non-specific binding and Results and Discus-
sion).
%NRT =
((
MFIS − NSBS) / (MFIPC − NSBPC))T ∗ 100% (1)
where subscript T represents T. gondii or T. spiralis in
the considered case.
Statistical analysis
All statistical evaluations were performed with SPSS.
To specify the performance of the bead-based assay,
expressed in area under the curve (AUC), receiving
operator characteristic (ROC) calculations were per-
formed using the experimental infection status as gold
standard. Analysis was performed on the %NR of the
BBA and E3-TOX, and OD450nmof the other ELISAs.
ROC calculations were also performed on limited sets of
serum from the experimental infection. These sets con-
sisted of all samples minus serum samples drawn 5 days
after inoculation with T. gondii (n = 408) and all sam-
ples minus serum samples drawn 5, 12 and 19 days
after inoculation with T. spiralis (n = 360), for the T.
gondii and T. spiralis indirect tests, respectively. To
further specify the tests, diagnostic Sensitivity (Se), Spe-
cificity (Sp) and cut-off values at maximum Youden
Index were determined from ROC calculations [10].
To assess the agreement between tests, the marginal
homogeneity of paired proportions [11] were tested by
McNemar’s in a 2 × 2 contingency table. Furthermore,
inter-rater agreement was calculated using Cohen’s
Kappa. For this, serum responses of all tests were
labelled 0 (negative), when they were below the cut-off
value or 1 (positive) when they were equal or above cut-
off value. These dichotomized outcomes where then
evaluated against the dichotomized outcomes of the
other tests. Kappa values between 0.40 - 0.59, 0.60 -
0.79 and ≥ 0.80 are interpreted as moderate, substantial
and excellent agreement, respectively [11].
The apparent prevalence (AP) is the proportion of the
population which tests positive in the test, which is a
measure of true prevalence (TP) and the capability of
the test to predict true positives and negatives, and it
was calculated as [12]:
AP = Se ∗ TP + (1− Sp) ∗ (1− TP) (2)
where TP is the proportion of actual infected animals
which was calculated by:
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TP = n/N (3)
where n is the number of sera which originate from
inoculated animals, and N is the total number of sera.
Results and discussion
Results from T. gondii and T. spiralis negative field sam-
ples, negative control serum of the experimental infec-
tion and secondary antibody binding alone (Table 1)
showed that the height of NSB responses is foremost
dependent of the presence of serum. Observing that
negative sera due to NSB can reach the same or higher
responses as for example positive control serum of
250,000 MFI on T. gondii and 500,000 MFI on T. spira-
lis beads (data not presented), it is concluded that cor-
rection for NSB is necessary to prevent false positive
results.
The results of T. gondii and T. spiralis negative field
sera illustrate that the response of the reference beads
could not directly be used as a measure for non-specific
binding. The log linear relations between responses of
reference beads and T. gondii or T. spiralis beads are
depicted in Figures 1 and 2, and the relations were
expressed as:
logNSB(TOX) = logMFIREF∗0.404 + 2.818 (4)
logNSB(TRI) = logMFIREF∗0.646 + 1.863 (5)
The slopes of the two regression lines indicate that T.
gondii beads are subject to less NSB as compared to T.
spiralis beads. This finding may be explained by, for
example, variable concentration of antigens on the bead,
differences in antigen molecule structures and orienta-
tion on the bead surface and/or the affinity between
non-specific antibodies and the unoccupied bead surface
or coupled antigens. A variety in antigen composition
between biologically produced batches can therefore be
of importance in relation to NSB. To test whether the
correction factor to calculate bead correlated NSB is
stable between batches of antigen, further evaluation is
necessary. Subtraction of uncorrected responses of refer-
ence beads, according to formula 1, would lead to an
underestimation or overestimation of NSB for responses
below and above 53,480 and 183,110 for T. gondii and
T. spiralis, respectively.
Results of ROC calculations, presented in Table 2,
showed that the AUC, a measure of agreement between
specific responses and the experimental infection status
of the animals, of all indirect tests ranged between 0.837
and 0.930 for T. gondii and 0.855 and 0.879 for T. spira-
lis. These values indicate that there is a good relation
between the responses of all indirect tests and the infec-
tion status of the animals.
Table 1 Non specific binding responses of T.gondii and T. spiralisnegative serum sets and conjugate alone
Serum Bead identification n Min. response (MFI) Max. response (MFI) Mean response (MFI) SE
Buffer REF 98 300 600 500 5
TOX 98 3,900 4,700 4,300 19
TRI 98 3,200 3,900 3,500 17
(T. gondii or T. spiralis) negative field sera REF 947 400 491,500 53,700 2,200
TOX 932 4,200 269,200 47,900 1,100
TRI 945 3,400 505,500 75,300 2,300
Experimental infection negative control sera REF 36 1,100 1,900 4,100 600
TOX 36 4,900 45,500 21,500 1,900
TRI 36 4,200 34,800 10,400 1,000
Minimum, maximum and mean response signals of reference (REF), T. gondii (TOX) and T. spiralis (TRI) coupled beads after incubation of buffer, negative field
sera (without positive responders in T. gondii ELISA) and sera of the negative control animals of the experimental infection. n, number of tested sera; SE, standard
error
Figure 1 Estimation of T. gondii non-specific binding correction
factor. Log transformed responses of T. gondii negative swine field
sera on non-coupled beads (x-axis) versus T. gondii coupled beads
(y-axis). Linear regression line (log y = 0.404* log x + 2.818), 95%CI
lines and the linear R2 are presented.
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A perfect test is a test in which the responses corre-
spond 100%, i.e. an AUC of 1.000, with the values of the
test to which it is compared. The imperfect AUC values
(< 1.000) found in our study (Table 3) can partly be
explained by a late immunological development of anti-
bodies, which is associated to the time course of parasite
antigen expression and the immune response of infected
animals. Evidence from earlier studies showed that mus-
cle larvae, depending on the infection dose, can be
found in pork by digestion or trichinoscopy as early as
17 days p.i. [13]. Other studies showed that T. spiralis
ES could be measured within the developing muscle
larvae and its cuticular surface as early as 14 days p.i.
[14] and in the surrounding tissue around 15 days p.i.
[15]. Consequently, the response time, i.e. the time of
development of antibodies against the antigen used in
the indirect T. spiralis assays, is affected by this late pro-
duction. Porcine IgG antibodies against ES are devel-
oped approximately 3 to 4 weeks after infection with
5,000 muscle larvae [16,17]. Porcine IgG antibodies
against T. gondii tachyzoites are produced much earlier
in time and can be detectable after one to two weeks of
infection [18]. In our study, the sera used for ROC cal-
culations originated from animals which were collected
on a weekly basis [8]. Samples drawn 5 days after T.
gondii inoculation and 5, 12 and 19 days after T. spiralis
inoculation would produce a false negative result when
compared to the experimental infection status, resulting
in lower AUC values. Calculations of ROC curves with-
out these sera resulted in notably higher AUC values of
0.995, 0.999, 0.998 and 0.999 for BBA-TOX, E3-TOX,
BBA-TRI and E-TRI, respectively (Figures 3 and 4).
According to data of test performances and inter test
agreement, presented in Table 3, the T. gondii and T.
spiralis bead assays agree excellently with their respec-
tive highest scoring tests, i.e. with the E-TOX3 and E-
TRI, respectively. Marginal homogeneity by McNemars
test, a test which determines the equality between posi-
tive and negative test proportions of one test compared
to the other, indicated that there is a balance between
BBA-TOX and E-TOX3.
Figure 2 Estimation of T. spiralis non-specific binding
correction factor. Log transformed responses of T. spiralis negative
swine field sera on non-coupled beads (x-axis) versus T. spiralis
coupled beads (y-axis). Linear regression line (log y = 0.646*log x +
1.863), 95%CI lines and the linear R2 are presented
Table 2 Infection status based specifications of bead-
based assay and ELISA tests calculated by ROC analysis
ROC analysis
Maximum Youden
Index
test AUC SE P 95% CI Cut-off Se Sp
BBA-TOX 0.911 0.015 < 0.001 0.881-0.940 13.90 0.86 0.96
E1-TOX 0.837 0.018 < 0.001 0.800-0.873 0.369 0.64 0.95
E2-TOX 0.865 0.018 < 0.001 0.829-0.901 0.174 0.76 0.93
E3-TOX 0.930 0.013 < 0.001 0.904-0.956 26.90 0.84 0.99
BBA-TRI 0.855 0.018 < 0.001 0.819-0.890 4.65 0.68 1.00
E-TRI 0.879 0.016 < 0.001 0.849-0.912 0.018 0.72 0.95
ROC analyses of a T. gondii and T. spiralis bead-based assay, three T. gondii
and one T. spiralis ELISAs using responses of porcine serum samples from an
experimental infection calculated against their infection status. AUC, area
under the curve; SE, standard error of AUC; P, P-value; 95% CI, interval at a
95% confidence; Se, sensitivity; Sp, specificity; BBA-TOX, T. gondii antigen
coupled bead-based assay; E1-TOX, RIVM in-house T. gondii ELISA, E2-TOX:
Safepath T. gondii ELISA, E3-TOX, ID-VET T. gondii ELISA; BBA-TRI, T. spiralis
antigen coupled bead-based assay and E-TRI, Safepath T. spiralis ELISA
Table 3 Inter-test agreement between assays calculated
by McNemar’s and Cohen’s Kappa analysis
McNemar’s test Yates
correction
Cohen’s Kappa
Test comparison P  * 95% CI
BBA-TOX vs. E1-
TOX
< 0.001 0.676 0.607-
0.744
BBA-TOX vs. E2-
TOX
0.01 0.802 0.746-
0.857
BBA-TOX vs. E3-
TOX
0.06 0.932 0.900-
0.966
E1-TOX vs. E2-TOX < 0.001 0.752 0.690-
0.814
E1-TOX vs. E3-TOX < 0.001 0.723 0.658-
0.787
E2-TOX vs. E3-TOX 0.233 0.797 0.740-
0.853
BBA-TRI vs. E-TRI < 0.001 0.880 0.835-
0.925
Inter-test agreement calculations comparing between dichotomized results of
tests. P, probability; , Cohen’s Kappa value; 95% CI, interval at a 95%
confidence; BBA-TOX, T. gondii antigen coupled bead-based assay; E1-TOX,
RIVM in-house T. gondii ELISA; E2-TOX, Safepath T. gondii ELISA; E3-TOX, ID-
VET T. gondii ELISA; BBA-TRI, T. spiralis antigen coupled bead-based assay and
E-TRI, Safepath T. spiralis ELISA. * indicates that all values were statistically
significant (P < 0.001)
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The potential use of the bead based test is prevention
of T. gondii and/or T. spiralis infections in pork to enter
the human food chain. Nonetheless, direct parasitologi-
cal testing, like T. spiralis artificial digestion, are more
reliable methods to test for present infection in meat.
Existing T. gondii direct tests are either laborious, e.g.
due to the need of pathogen extraction in PCR [19], or
are undesirable because of utilization of experimental
animals, like in cat and mice bioassays [20], to deter-
mine the infectious status of meat. In the case of T. gon-
dii infections, serological testing is the next best option
to perform on large scale. Unfortunately, due to the
time window between infection and development of spe-
cific antibody responses, serological tests are less reliable
for detection on individual scale; however, they can be
used for monitoring purposes on herd level [21].
To prevent human T. gondii and T. spiralis infections
through consumption of infected pork by serological
monitoring of pig herds, a high sensitivity of 99% [22],
and an approximation of AP to TP (Table 4) is desired.
None of the assays used for this paper met this require-
ment. However, when ROC calculations were restricted
to serum samples in which antibody responses were to
be expected, as was described above, the sensitivity was
97% and 99% for BBA-TOX and BBA-TRI, respectively
(data not presented). Subsequent calculations for true
and apparent prevalence resulted in an overall T. gondii
TP of 52.7% and AP’s of 51.5% and 53.3% for BBA and
ELISA, respectively. The overall TP of T. spiralis was
44.4% while the APs were 44.1% and 44.3% for BBA and
ELISA, respectively (data not presented). These data
would indicate that the combined bead-based assay is
applicable for serological monitoring purposes.
Although we compared our new T. gondii and T. spir-
alis bead test with a limited selection of available ELI-
SAs, the test specifications and agreement between tests
examined in this study indicate that the combined bead
test equals or is superior to other tests. However, all cal-
culations have been based upon tests using serum sam-
ples of experimentally infected pigs, which were exposed
Figure 3 ROC curves of T. gondii assays calculated with a
limited serum set from experimental infection. ROC analysis of a
T. gondii bead-based assay and three ELISAs using responses from a
set of serum samples, consisting of sera from experimentally
infected pigs minus sera drawn on day 5 after inoculation with T.
gondii, against their infection status. AUC, area under the curve; 95%
CI, interval of AUC at 95% confidence; BBA-TOX, T. gondii antigen
coupled bead-based assay; E1-TOX, RIVM in-house T. gondii ELISA,
E2-TOX: Safepath T. gondii ELISA, E3-TOX, ID-VET T. gondii ELISA.
Figure 4 ROC curves of T. spiralis assays calculated with a
limited serum set from experimental infection. ROC analysis of a
T. spiralis bead-based assay and ELISA using responses from a set of
serum samples, consisting of sera from experimentally infected pigs
minus sera drawn on days 5, 12 and 19 after inoculation with T.
spiralis, against their infection status. AUC, area under the curve;
95%CI, interval of AUC at 95% confidence; BBA-TRI, T. spiralis antigen
coupled bead-based assay; E-TRI: Safepath T. gondii ELISA.
Table 4 Comparison of true and apparent prevalence’s of
pig sera between indirect assays
test True prevalence Apparent prevalence
BBA-TOX 56.6% 50.1%
E1-TOX 38.3%
E2-TOX 45.9%
E3-TOX 48.0%
BBA-TRI 58.6% 39.8%
E-TRI 44.2%
BBA-TOX, T. gondii antigen coupled bead-based assay; E1-TOX, RIVM in-house
T. gondii ELISA; E2-TOX, Safepath T. gondii ELISA; E3-TOX, ID-VET T. gondii
ELISA; BBA-TRI, T. spiralis antigen coupled bead-based assay and E-TRI,
Safepath T. spiralis ELISA
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to high doses of parasites. Conventionally raised animals
are likely to be infected by lower doses of parasites, and
sero-conversion may be detected later in time [16-18].
Therefore, to determine the applicability of this bead-
based test for the use of indirect detection of infection,
it is advisable to further evaluate the test by the use of
serum samples of naturally infected pigs.
Conclusions
In conclusion, this initial evaluation study of a novel bead-
based assay capable of a simultaneous detection of serolo-
gical antibodies against T. gondii and T. spiralis antigens
indicates that the test results correspond very well to the
infection status of the animals, and, furthermore, there is a
substantial to excellent agreement with other indirect
tests. In order to estimate the applicability of this test for
purposes of serological monitoring, further testing of sera
from naturally infected animals is required.
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